文献速递胸部肿瘤放疗中枢神经肿瘤放疗

ESTRO专家共识:早期小细胞肺癌术后胸部放疗与预防性颅脑照射的患者选择

The role of postoperative thoracic radiotherapy and prophylactic cranial irradiation in early stage small cell lung cancer: Patient selection among ESTRO experts.
PubMed 文献 · Radiother Oncol · 2019-12-27

结果显示,淋巴结阳性患者多数专家推荐PCI和TRT;老年淋巴结阴性患者多数专家不推荐TRT或PCI。结论认为对已切除SCLC应考虑PCI和TRT,并应在共享决策中与患者讨论。

要点

  • 淋巴结阳性的已切除SCLC患者,多数专家推荐PCI和TRT。
  • 老年淋巴结阴性的已切除SCLC患者,多数专家不推荐TRT或PCI。
  • PCI和TRT应在共享决策框架下与患者讨论。

核心结论

  • 对已切除SCLC患者应考虑PCI和TRT,并应在共享决策中与患者讨论。

研究设计与样本

  • 将治疗策略转化为决策树并分析共识与分歧。

主要发现

  • 淋巴结阳性的已切除SCLC患者,多数专家推荐PCI和TRT。
  • 老年淋巴结阴性的已切除SCLC患者,多数专家不推荐TRT或PCI。

临床怎么用

  • 对已切除SCLC淋巴结阳性患者可考虑PCI和TRT。
  • 对老年淋巴结阴性患者多数专家不推荐TRT或PCI。
  • 治疗决策应与患者共享讨论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The role of prophylactic cranial irradiation (PCI) and thoracic radiotherapy (TRT) is unclear in resected small cell lung cancer (SCLC). METHODS: Thirteen European radiotherapy experts on SCLC were asked to describe their strategies on PCI and TRT for patients with resected SCLC. The treatment strategies were converted into decision trees and analyzed for consensus and discrepancies. RESULTS: For patients with resected SCLC and positive lymph nodes most experts recommend prophylactic cranial irradiation and thoracic radiotherapy. For elderly patients with resected node negative SCLC, most experts do not recommend thoracic radiotherapy or prophylactic cranial irradiation. CONCLUSION: PCI and TRT are considered in patients with resected SCLC and these treatments should be discussed with the patient in the context of shared decision-making.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Putora PM, De Ruysscher D, Glatzer M, et al. The role of postoperative thoracic radiotherapy and prophylactic cranial irradiation in early stage small cell lung cancer: Patient selection among ESTRO experts. Radiother Oncol. 2019. PMID: 31887577. doi:10.1016/j.radonc.2019.11.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。